Frederic Sweeney, Ph.D.


Frederic is an entrepreneur-in-residence and Chief Business Officer of Versant portfolio company Northern Biologics. Fred’s career spans academic research, private and corporate venture capital as well as operations in small and large companies.


Most recently, Fred was VP of corporate development and head of strategic financing of bioMérieux. Prior to bioMérieux, he was head of business development and strategy at T2 Biosystems.

Fred obtained his BSc in Biochemistry at McGill University and then completed a Ph.D. focused on DNA repair, signal transduction and structural biology as a Terry Fox Scholar at the University of Toronto.